Your email has been successfully added to our mailing list.

×
-0.0259259259259259 -0.0555555555555555 -0.0851851851851852 -0.0302407407407408 0.0518518518518519 0.0023518518518518 -0.0194444444444445 -0.012962962962963
Stock impact report

Xenetic Biosciences doubles up on heavy volume [Seeking Alpha]

Xenetic Biosciences, Inc. (XBIO) 
NASDAQ:AMEX Investor Relations: ir.xeneticbio.com
Company Research Source: Seeking Alpha
Shares in nanocap Xenetic Biosciences (NASDAQ: XBIO ) are surging today, to $5.63. At just under 6M shares traded, volume is running more than 36 times average. The company's lead product candidate is XBIO-101, a small molecule immunomodulator and interferon inducer focused on treating progesterone-resistant endometrial cancer. See all stocks on the move » Now read: Immune Pharmaceuticals And Bertilimumab: A Work In Progress » Show less Read more
Impact Snapshot
Event Time:
XBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for XBIO alerts
Opt-in for
XBIO alerts

from News Quantified
Opt-in for
XBIO alerts

from News Quantified